Matches in SemOpenAlex for { <https://semopenalex.org/work/W3169496688> ?p ?o ?g. }
- W3169496688 endingPage "939" @default.
- W3169496688 startingPage "921" @default.
- W3169496688 abstract "To improve the success rate of current preclinical drug trials, there is a growing need for more complex and relevant models that can help predict clinical resistance to anticancer agents. Here, we present a three-dimensional (3D) technology, based on biomimetic collagen scaffolds, that enables the modeling of the tumor hypoxic state and the prediction of in vivo chemotherapy responses in terms of efficacy, molecular alterations, and emergence of resistance mechanisms. The human breast cancer cell lines MDA-MB-231 (triple negative) and MCF-7 (luminal A) were treated with scaling doses of doxorubicin in monolayer cultures, 3D collagen scaffolds, or orthotopically transplanted murine models. Lineage-specific resistance mechanisms were revealed by the 3D tumor model. Reduced drug uptake, increased drug efflux, and drug lysosomal confinement were observed in triple-negative MDA-MB-231 cells. In luminal A MCF-7 cells, the selection of a drug-resistant subline from parental cells with deregulation of p53 pathways occurred. These cells were demonstrated to be insensitive to DNA damage. Transcriptome analysis was carried out to identify differentially expressed genes (DEGs) in treated cells. DEG evaluation in breast cancer patients demonstrated their potential role as predictive biomarkers. High expression of the transporter associated with antigen processing 1 (TAP1) and the tumor protein p53-inducible protein 3 (TP53I3) was associated with shorter relapse in patients affected by ER+ breast tumor. Likewise, the same clinical outcome was associated with high expression of the lysosomal-associated membrane protein 1 LAMP1 in triple-negative breast cancer. Hypoxia inhibition by resveratrol treatment was found to partially re-sensitize cells to doxorubicin treatment. Our model might improve preclinical in vitro analysis for the translation of anticancer compounds as it provides: (a) more accurate data on drug efficacy and (b) enhanced understanding of resistance mechanisms and molecular drivers." @default.
- W3169496688 created "2021-06-22" @default.
- W3169496688 creator A5015241599 @default.
- W3169496688 creator A5016193335 @default.
- W3169496688 creator A5017629308 @default.
- W3169496688 creator A5022603320 @default.
- W3169496688 creator A5040242292 @default.
- W3169496688 creator A5046802560 @default.
- W3169496688 creator A5047952050 @default.
- W3169496688 creator A5050243008 @default.
- W3169496688 creator A5071119383 @default.
- W3169496688 creator A5071468347 @default.
- W3169496688 creator A5072404265 @default.
- W3169496688 creator A5073084278 @default.
- W3169496688 creator A5073761054 @default.
- W3169496688 creator A5074249448 @default.
- W3169496688 creator A5075055655 @default.
- W3169496688 date "2021-07-10" @default.
- W3169496688 modified "2023-10-17" @default.
- W3169496688 title "Lineage‐specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic culture" @default.
- W3169496688 cites W1233276 @default.
- W3169496688 cites W1271389891 @default.
- W3169496688 cites W1662360083 @default.
- W3169496688 cites W1961026612 @default.
- W3169496688 cites W1970590657 @default.
- W3169496688 cites W1978747495 @default.
- W3169496688 cites W1982037430 @default.
- W3169496688 cites W1997362383 @default.
- W3169496688 cites W1999078067 @default.
- W3169496688 cites W2002521417 @default.
- W3169496688 cites W2006574212 @default.
- W3169496688 cites W2009798744 @default.
- W3169496688 cites W2026916005 @default.
- W3169496688 cites W2033346155 @default.
- W3169496688 cites W2047316426 @default.
- W3169496688 cites W2055529283 @default.
- W3169496688 cites W2057280155 @default.
- W3169496688 cites W2064297038 @default.
- W3169496688 cites W2069518226 @default.
- W3169496688 cites W2103980474 @default.
- W3169496688 cites W2110756650 @default.
- W3169496688 cites W2113344831 @default.
- W3169496688 cites W2123232388 @default.
- W3169496688 cites W2127208331 @default.
- W3169496688 cites W2131487381 @default.
- W3169496688 cites W2132031002 @default.
- W3169496688 cites W2132566055 @default.
- W3169496688 cites W2147043620 @default.
- W3169496688 cites W2149994120 @default.
- W3169496688 cites W2279226389 @default.
- W3169496688 cites W2396983889 @default.
- W3169496688 cites W2471907651 @default.
- W3169496688 cites W2471940455 @default.
- W3169496688 cites W2489443540 @default.
- W3169496688 cites W2514972769 @default.
- W3169496688 cites W2536384041 @default.
- W3169496688 cites W2593215112 @default.
- W3169496688 cites W2626777224 @default.
- W3169496688 cites W2748363733 @default.
- W3169496688 cites W2766363222 @default.
- W3169496688 cites W2766710286 @default.
- W3169496688 cites W2767274043 @default.
- W3169496688 cites W2773861321 @default.
- W3169496688 cites W2783495684 @default.
- W3169496688 cites W2791017844 @default.
- W3169496688 cites W2795248085 @default.
- W3169496688 cites W2802173235 @default.
- W3169496688 cites W2804173672 @default.
- W3169496688 cites W2809205410 @default.
- W3169496688 cites W2883808667 @default.
- W3169496688 cites W2886855629 @default.
- W3169496688 cites W2888228317 @default.
- W3169496688 cites W2889646458 @default.
- W3169496688 cites W2898144712 @default.
- W3169496688 cites W2898416763 @default.
- W3169496688 cites W2898645438 @default.
- W3169496688 cites W2901604183 @default.
- W3169496688 cites W2911860253 @default.
- W3169496688 cites W2912817458 @default.
- W3169496688 cites W2912920367 @default.
- W3169496688 cites W2940729097 @default.
- W3169496688 cites W2941467331 @default.
- W3169496688 cites W2947971132 @default.
- W3169496688 cites W2969825469 @default.
- W3169496688 cites W2970918838 @default.
- W3169496688 cites W2986258844 @default.
- W3169496688 cites W2987284967 @default.
- W3169496688 cites W3007116438 @default.
- W3169496688 cites W3011569436 @default.
- W3169496688 cites W3012441117 @default.
- W3169496688 cites W3014678709 @default.
- W3169496688 cites W3016071795 @default.
- W3169496688 cites W3026944009 @default.
- W3169496688 cites W3042505563 @default.
- W3169496688 cites W3100887717 @default.
- W3169496688 cites W3119252947 @default.
- W3169496688 cites W3129134217 @default.
- W3169496688 cites W3134387579 @default.